Morgan Stanley has upgraded PTC Therapeutics (NASDAQ:PTCT), while downgrading Immuneering (NASDAQ:IMRX) and Amicus Therapeutics (NASDAQ:FOLD). The investment bank raised its rating on PTC (NASDAQ:PTCT ...
Qure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by Guggenheim in a report released on ...
uniQure (NASDAQ:QURE – Get Free Report) shares saw strong trading volume on Wednesday after The Goldman Sachs Group raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback